A brain-computer interface that allowed a man, 45, with ALS to communicate using recordings of his own voice has won a $7,500 ...

Affiliate links for the products on this page are from partners that compensate us and terms apply to offers listed (see our advertiser disclosure with our list of partners for more details ...

Debiopharm further describes AbYlink as a one-step method that results in stable conjugation at defined and invariable sites on the Fc domain of an antibody, with no impact on antigen-binding regions, ...

Treatment with regulatory T-cells, known as Tregs, was well tolerated and seemed to reduce disease activity in a small ...

Pfizer (PFE) will showcase data across its portfolio of potential breakthrough cancer medicines at the 2025 American ...

Additionally, the presence of certepetide in the tumor microenvironment (TME) is expected to reduce the immunosuppressive nature of the TME further improving patient response and outcomes to the ADC ...

It's a win-win, and it's why everything on iStock is only available royalty-free — including all Alternative Therapy images and footage. What kinds of royalty-free files are available on iStock? How ...

Oral therapy data presented at ASH CellCentric, a U.K-based biotech, has just unveiled early-stage data from a potential first-in-class oral therapy at the American Society of Hematology (ASH ...

The average cost of testosterone therapy will depend on the type of treatment, your location, and if you have health insurance. Some health insurance plans may cover the full cost, while others might ...

Making her inaugural presidential speech in London, Rachael Wardell highlighted pressures in the SEND system as one of the key challenges facing directors of children’s services (DCS) over the coming ...

“We have deliberately made investment in the next-generation technologies which we believe will redefine oncology care, like ADCs [and] radioconjugates ... to cell therapy, and that's ...

Bluebird Bio and Xcellbio have entered into an agreement to support the commercialization of Lyfgenia (lovotibeglogene autotemcel), Bluebird’s gene therapy for sickle cell disease, incorporating ...